Use of transrectal ultrasound for high dose rate interstitial brachytherapy for patients of carcinoma of uterine cervix

다국어 초록 (Multilingual Abstract)

Objective: Transrectal ultrasound (TRUS) has been widely used for guiding prostate implants, but not much for interstitial brachytherapy (IBT) of cervix cancer. The aim of our study is to report our experience with TRUS guided high dose rate (HDR) IBT in patients with carcinoma of uterine cervix.
Methods: During the year 2005-2006, 25 patients of cervical cancer not suitable for intracavitary radiotherapy (ICRT),were enrolled in this prospective study. We used B-K Medical USG machine (Falcon 2101) equipped with a TRUS probe (8658) having a transducer of 7.5 MHz for IBT. Post procedure, a CT scan was done for verification of needle position and treatment planning. Two weekly sessions of HDR IBT of 8-10 Gy each were given after pelvic external beam radiation therapy.
Results: A total of 40 IBT procedures were performed in 25 patients. Average duration of implant procedure was 50minutes. There was no uterine perforation in any of 11 patients in whom central tandem was used. CT scan did not show needle perforation of bladder/rectum in any of the patients. During perioperative period, only 1 procedure (2.5%) was associated with hematuria which stopped within 6 hours. Severe late toxicity was observed in 3 (12%)patients. Overall pelvic control rate was 64%.
Conclusion: Our experience suggests that TRUS is a practical and effective imaging device for guiding the IBT procedure of cervical cancer patients. It helps in accurate placements of needles thus avoiding the injury to normal pelvic structures.

참고문헌 (Reference)

1 Brascho DJ, "Use of ultrasonography in planning intracavitary radiotherapy of endometrial carcinoma" 129 : 163-167, 1978

2 Kini VR, "Use of three-dimensional radiation therapy planning tools and intraoperative ultrasound to evaluate high dose rate prostate brachytherapy implants" 43 : 571-578, 1999

3 Erickson B, "Ultrasound-guided transperineal interstitial implantation of pelvic malignancies: description of the technique" 11 : 107-113, 1995

4 Granal CO, "Ultrasound used for assessing the in situ position of intrauterine tandems" 18 : 334-338, 1984

5 Rotmensch J, "Ultrasound guidance for placement of difficult intracavitary implants" 54 : 159-162, 1994

6 Syed AMN, "Transperineal interstitial-intracavitary Syed-Neblett applicator in the treatment of carcinoma of the uterine cervix" 2 : 1-13, 1986

7 Holm HH, "Transperineal 125iodine seed implantation in prostatic cancer guided by transrectal ultrasonography" 130 : 283-286, 1983

8 Nag S, "The use of fluoroscopy to guide needle placement in interstitial gynecological brachytherapy" 40 : 415-420, 1998

9 Nag S, "The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix" 48 : 201-211, 2000

10 Haie-Meder C, "Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV" 74 : 235-245, 2005

11 Potter R, "Recommendations from Gynaecological (GYN) GEC ESTRO Working Group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology" 78 : 67-77, 2006

12 Perez CA, "Perez and Brady's principles and practice of radiation oncology" Lippincott Williams & Wilkins 1532-1609, 2008

13 Monk BJ, "Open interstitial brachytherapy for the treatment of local-regional recurrences of uterine corpus and cervix cancer after primary surgery" 52 : 222-228, 1994

14 Viswanathan A, "Magnetic resonance-guided interstitial therapy for vaginal recurrence of endometrial cancer" 66 : 91-99, 2006

15 Patel FD, "Low dose rate vs. high dose rate brachytherapy in the treatment of carcinoma of the uterine cervix: a clinical trial" 28 : 335-341, 1994

16 Recio FO, "Laparoscopic-assisted application of interstitial brachytherapy for locally advanced cervical carcinoma: results of a pilot study" 40 : 411-414, 1998

17 Fleischer AC, "Jones HW 3rd. Intraoperative guidance for intrauterine procedures with transrectal sonography" 176 : 576-577, 1990

18 Granai CO, "Intraoperative real-time ultrasonography during intrauterine tandem placement" 67 : 112-114, 1986

19 Martinez A, "Interstitial therapy of perineal and gynecological malignancies" 9 : 409-416, 1983

20 Erickson B, "Interstitial implantation of gynecological malignancies in Principles and practice of brachytherapy" Futura Publishing Company 515-552, 1997

21 Corn BW, "Improved treatment planning for the Syed-Neblett template using endorectal-coil magnetic resonance and intraoperative (laparotomy/laparoscopy) guidance: a new integrated technique for hysterectomized women with vaginal tumors" 56 : 255-261, 1995

22 Beriwal S, "High-dose-rate interstitial brachytherapy for gynecologic malignancies" 5 : 218-222, 2006

23 Demanes DJ, "High dose rate transperineal interstitial brachytherapy for cervical cancer: high pelvic control and low complication rates" 45 : 105-112, 1999

24 Erickson B, "CT-guided interstitial implantation of gynecologic malignancies" 36 : 699-709, 1996

25 Stock RG, "A new technique for performing Syed-Neblett template interstitial implants for gynecologic malignancies using transrectal-ultrasound guidance" 37 : 819-825, 1997

26 Martinez A, "A multiple-site perineal applicator (MUPIT) for treatment of prostatic, anorectal, and gynecologic malignancies" 10 : 297-305, 1984